Mar 19, 2025, 10:19 by ASAM Weekly Editors

Guest Editorial by Nora Volkow - Advancing Reduction of Drug Use as an Endpoint in Addiction Treatment Trials

Mar 18, 2025, 18:21 by Sarah Shelson

Mar 18, 2025, 09:02 by Sarah Shelson

Mar 18, 2025, 08:14 by Kenneth Minkoff, MD

For many people trying to recover from a substance use disorder, perhaps for the majority, abstinence may be the most appropriate treatment objective. But complete abstinence is sometimes not achievable, even in the long-term, and there is a need for new treatment approaches that recognize the clinical value of reduced use.

Mar 14, 2025, 17:00 by Sarah Shelson

Mar 12, 2025, 14:30 by ASAM Weekly Editors

The association between buprenorphine doses above 16 milligrams and treatment retention

Mar 11, 2025, 17:08 by Sarah Shelson

Mar 5, 2025, 16:54 by Sarah Shelson

Mar 3, 2025, 12:11 by Emily Brunner, MD, DFASAM, Chwen-Yuen A. Chen, MD, FACP, FASAM, Chinyere Ogbonna, MD, MPH, Tricia Wright, MD, MS, FACOG, DFASAM

This guideline was developed to help clinicians determine when the risks of continued BZD prescribing outweigh the benefits for a given patient and how to safely taper the medication when indicated. Existing guidelines generally recommend limiting duration of BZD use to 2-4 weeks (except for limited conditions such as severe treatment-resistant generalized anxiety disorder, complex seizure disorders, spasticity, and sleep disorders involving abnormal movements). However, long-term BZD prescribing remains prevalent.

Feb 27, 2025, 18:41 by Sarah Shelson

Feb 26, 2025, 17:22 by Sarah Shelson

Feb 26, 2025, 09:59 by ASAM Weekly Editors

Guest Editorial: New Clinical Practice Guideline - Benzodiazepine Tapering

Feb 19, 2025, 10:38 by ASAM Weekly Editors

Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality

Feb 18, 2025, 14:22 by Sarah Shelson

Feb 12, 2025, 15:37 by ASAM Weekly Editors

Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders

Feb 10, 2025, 16:59 by Sarah Shelson

Feb 10, 2025, 09:51 by ASAM Weekly Editors

Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl

Feb 7, 2025, 16:06 by Kelly Corredor

Feb 3, 2025, 16:30 by Sarah Shelson

Jan 31, 2025, 14:06 by Sarah Shelson